North America Smoking Cessation And Nicotine De Addictions Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 38.58 Billion |
 Market Size (Forecast Year) |
USD 221.27 Billion |
 CAGR |
% |
| Major Markets Players |
>北美戒烟和尼古丁戒瘾市场，按产品类型（含尼古丁和不含尼古丁）、治疗类型（药理、疗法和其他）、分销渠道（线上、线下）、最终用户（Z 世代、千禧一代、X 世代和沉默的一代）划分 - 行业趋势和预测至 2029 年
市场分析和规模
全世界吸烟成瘾的人数正在迅速增长。这一人群主要由青少年和劳动人口组成。吸烟导致的死亡率极高。戒烟意愿的日益增长以及吸烟带来的众多健康风险为公司开发新型戒烟产品提供了强大的动力。
Data Bridge Market Research 分析称，2021 年戒烟和尼古丁脱瘾市场价值为 385.8 亿美元，预计到 2029 年将达到 2212.7 亿美元，2022 年至 2029 年预测期内的复合年增长率为 24.4%。
市场定义
戒烟是戒烟或尼古丁戒瘾的一部分。烟草中含有尼古丁，众所周知，尼古丁会通过释放多巴胺、γ-氨基丁酸 (GABA) 和谷氨酸等神经递质导致成瘾。戒烟有助于治疗香烟和烟草成瘾者。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
产品类型（含尼古丁和不含尼古丁）、治疗类型（药理学、疗法和其他）分销渠道（线上、线下）、最终用户（Z 世代、千禧一代、X 世代和沉默的一代） |
|
覆盖国家 |
美国、加拿大和墨西哥 |
|
涵盖的市场参与者 |
Imperial Brands（英国）、22nd Century Group, Inc（美国）、辉瑞公司（美国）、Dr. Reddy's Laboratories Ltd（印度）、葛兰素史克公司（英国）、英美烟草公司（英国）、Cambrex Corporation（美国）、Cipla Inc.（美国）、Fertin Pharma（丹麦）、强生私人有限公司（美国）、Perrigo Company Plc（爱尔兰） |
|
机会 |
|
戒烟和尼古丁戒瘾市场动态
驱动程序
- 世界各地尝试戒烟的人数增加
One of the major factors driving the growth of the smoking cessation and nicotine de-addiction market is the increase in the number of people attempting to quit smoking around the world. Due to the toxic effects of nicotine and cigarette addiction on the cardiac and respiratory systems, the government emphasizes strict regulations to control nicotine and cigarette addiction, and high taxes on tobacco products accelerate market growth. Furthermore, high adoption of unhealthy lifestyle options, rapid urbanization, and an increase in disposable income all benefit the smoking cessation and nicotine de-addiction market.
- Strict regulations laid down by government to control nicotine and cigarette addiction
The government is emphasising strict regulations to control nicotine and cigarette addiction due to the toxic effects on the cardiac and respiratory systems. Smoking bans in public places, high taxes on tobacco products, and financial support for smoking cessation therapies are examples of government smoking cessation policies. As a result, during the forecast period, the global market for smoking cessation and nicotine de-addiction products is expected to grow rapidly.
Opportunities
The introduction of improved and innovative nicotine replacement therapy products is expected to be a significant driving force in the growth of the smoking cessation and nicotine de-addiction market. The rising prevalence of target diseases such as chronic obstructive pulmonary disease (COPD), asthma, cardiac diseases, and lung cancer, as well as growing public awareness of the dangers of smoking, are expected to drive market growth. An educational institution continue to be active in organising various campaigns and programmes to spread information about the harmful effects and consequences of smoking in order to raise the awareness of the young population.
Restraints
Reluctance to accept the treatment, on the other hand, is expected to stymie market growth. The smoking cessation and nicotine de-addiction market is expected to face challenges due to a lack of awareness in the forecast period.
This smoking cessation and nicotine de-addictions market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the smoking cessation and nicotine de-addictions market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Smoking Cessation and Nicotine De-Addictions Market
COVID-19 diagnosis was five times more likely among e-cigarette users alone, but it is also associated with the dual risk of e-cigarettes and cigarettes, implying that e-cigarettes may be underlying risk factors for COVID-19. Tobacco use increases the risk of infection, the likelihood of complications, and the likelihood of disease spread. Only 30% of users reported that the current situation had influenced their tobacco use, with the most common consequences being a lack of tobacco products and higher prices. During the lockdown, 34% of tobacco users in the population studied quit smoking. 51 percent of those who left did so due to the lockdown and their concerns about COVID-19. As a result, the COVID-19 pandemic had a significant impact on the smoking cessation aids market.
Recent Development
- JB Chemicals & Pharmaceuticals will introduce medicated nicotine lozenges in May 2021 to help reduce the desire to consume or smoke tobacco.
- NFL Biosciences SA, a biopharmaceutical company developing botanical drugs for the treatment of addictions, will begin its CESTO II Phase II/III clinical trial in December 2021 to evaluate the efficacy and safety of its NFL-101 smoking cessation treatment.
North America Smoking Cessation and Nicotine De-Addictions Market Scope
The smoking cessation and nicotine de-addictions market is segmented on the basis of product type, treatment type, distribution channel and end-use. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- With Nicotine
- Without Nicotine
Treatment type
- Pharmacological
- Therapies
- Others
Distribution channels
- Online
- Offline
End user
- Generation Z
- Millennials
- Generation X
- Silent Generation
Smoking Cessation and Nicotine De-Addictions Market Regional Analysis/Insights
The smoking cessation and nicotine de-addictions market is analyzed and market size insights and trends are provided by country, product type, treatment type, distribution channel and end-user as referenced above.
The countries covered in the smoking cessation and nicotine de-addictions market report are U.S., Canada and Mexico.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
竞争格局和戒烟及尼古丁戒瘾市场份额分析
戒烟和尼古丁戒瘾市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、北美业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对戒烟和尼古丁戒瘾市场的关注有关。
戒烟和尼古丁戒瘾市场的一些主要参与者包括：
- 帝国品牌（英国）
- 22 世纪集团 (美国)
- 辉瑞公司（美国）
- Dr. Reddy's Laboratories Ltd（印度）
- 葛兰素史克公司 (英国)
- 英美烟草公司（英国）
- Cambrex 公司 (美国)
- Cipla Inc.（美国）
- Fertin Pharma（丹麦）
- 强生私人有限公司（美国）
- Perrigo Company Plc（爱尔兰）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRODUCT TYPE LIFE LINE CURVE
2.7 MULTIVARIATE MODELLING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END-USER COVERAGE GRID
2.11 DBMR MARKET CHALLENGE MATRIX
2.12 IMPORT-EXPORT DATA
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING ADOPTION OF E-CIGARETTES IS EXPECTED TO FUEL THE GROWTH OF THE MARKET
5.1.2 GROWING AWARENESS AMONG POPULATION OWING TO INCREASING DISEASES FROM SMOKING
5.1.3 ANTI-SMOKING POLICIES BY GOVERNMENT IS EXPECTED TO BOOST THE MARKET
5.2 RESTRAINTS
5.2.1 ADVERSE EFFECTS OF SMOKING CESSATION PRODUCTS
5.2.2 REGULATIONS ON E-CIGARETTES
5.3 OPPORTUNITIES
5.3.1 UNTAPPED ASIAN MARKET SUCH AS CHINA AND INDIA, AMONG OTHERS
5.3.2 INHALERS AND SPRAYS CAN BE AN OPPORTUNITY FOR SMOKING CESSATION PRODUCTS
5.4 CHALLENGE
5.4.1 LACK OF AWARENESS IN RURAL AREAS
6 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 WITH NICOTINE
6.2.1.1 E-CIGARETTES
6.2.1.2 NICOTINE PATCHES
6.2.1.3 NICOTINE GUMS
6.2.1.4 NICOTINE LOZENGES
6.2.1.4.1 REGULAR LOZENGES
6.2.1.4.2 MINI LOZENGES
6.2.1.4.3 SUBLINGUAL LOZENGES
6.2.1.5 NICOTINE TABLETS
6.3 WITHOUT NICOTINE
6.3.1.1 CHANTIX (VARENICLINE)
6.3.1.2 CYTISINE
6.3.1.3 ZYBAN (BUPROPION)
7 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY TREATMENT TYPE
7.1 OVERVIEW
7.2 PHARMACOLOGICAL
7.3 THERAPIES
7.4 OTHERS
8 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY DISTRIBUTION CHANNEL
8.1 OVERVIEW
8.2 OFFLINE
8.2.1 DE-ADDICTION CENTERS
8.2.2 HOSPITAL PHARMACIES
8.2.3 RETAIL PHARMACIES
8.2.4 RETAIL STORES
8.2.5 OTHERS
8.3 ONLINE
9 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY END-USER
9.1 OVERVIEW
9.2 MILLENNIALS
9.3 MILLENNIALS END-USER, BY PRODUCT TYPE
9.3.1 WITH NICOTINE
9.3.2 WITHOUT NICOTINE
9.4 GENERATION Z
9.5 GENERATION Z END-USER, BY PRODUCT TYPE
9.5.1 WITH NICOTINE
9.5.2 WITHOUT NICOTINE
9.6 GENERATION X
9.7 GENERATION X END-USER, BY PRODUCT TYPE
9.7.1 WITH NICOTINE
9.7.2 WITHOUT NICOTINE
9.8 SILENT GENERATION
9.9 SILENT GENERATION END-USER, BY PRODUCT TYPE
9.9.1 WITH NICOTINE
9.9.2 WITHOUT NICOTINE
10 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY GEOGRAPHY
10.1 NORTH AMERICA
10.1.1 U.S.
10.1.2 CANADA
10.1.3 MEXICO
11 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
11.2 MERGERS & ACQUISITIONS
11.3 NEW PRODUCT DEVELOPMENT & APPROVALS
11.4 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12 SWOT ANALYSIS AND DATA BRIDGE MARKET RESEARCH ANALYSIS
12.1 SWOT ANALYSIS
12.1.1 STRENGTH: STRONG GEOGRAPHICAL PRESENCE
12.1.2 WEAKNESS: LIMTED PRODUCT PORTFOLIO
12.1.3 OPPORTUNITY: INCREASING INVESTMENT IN R&D EXPENDITURE
12.1.4 THREAT: STRINGENT RULES AND REGULATIONS
12.2 DATABRIDGE MARKET RESEARCH ANALYSIS
13 COMPANY PROFILE
13.1 IMPERIAL BRANDS
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT UPDATE
13.2ND CENTURY GROUP, INC.
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT UPDATES
13.3 PFIZER INC.
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 BRAND PORTFOLIO
13.3.5 RECENT UPDATE
13.4 DR. REDDY’S LABORATORIES LTD.
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 BRAND PORTFOLIO
13.4.5 RECENT UPDATE
13.5 GLAXOSMITHKLINE PLC.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT UPDATE
13.6 ALKALON A/S
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT UPDATE
13.7 BRITISH AMERICAN TOBACCO
13.7.1 COMPANY SNAPSHOT
13.7.2 REVENUE ANALYSIS
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT UPDATES
13.8 CAMBREX CORPORATION
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT UPDATE
13.9 CIPLA INC.
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 BRAND PORTFOLIO
13.9.4 RECENT UPDATE
13.1 FERTIN PHARMA
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.10.3 RECENT UPDATE
13.11 JAPAN TOBACCO INC.
13.11.1 COMPANY SNAPSHOT
13.11.2 REVENUE ANALYSIS
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT UPDATE
13.12 JOHNSON & JOHNSON SERVICES, INC.
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT UPDATE
13.13 PERRIGO COMPANY PLC
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT UPDATE
13.14 STRIDES CONSUMER PRIVATE LIMITED
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT UPDATES
13.15 TAKEDA CONSUMER HEALTHCARE COMPANY LIMITED
13.15.1 COMPANY SNAPSHOT
13.15.2 PRODUCT PORTFOLIO
13.15.3 RECENT UPDATE
14 QUESTIONNAIRE
15 CONCLUSION
16 RELATED REPORTS
表格列表
LIST OF TABLES
TABLE 1 IMPORT DATA OF MANUFACTURED TOBACCO AND MANUFACTURED TOBACCO SUBSTITUTES AND "HOMOGENISED" OR "RECONSTITUTED" TOBACCO, TOBACCO EXTRACTS AND TOBACCO ESSENCES (EXCLUDING CIGARS, INCL. CHEROOTS, CIGARILLOS AND CIGARETTES); HS CODE - 2403 (USD THOUSAND)
TABLE 2 EXPORT DATA OF MANUFACTURED TOBACCO AND MANUFACTURED TOBACCO SUBSTITUTES AND "HOMOGENISED" OR "RECONSTITUTED" TOBACCO, TOBACCO EXTRACTS AND TOBACCO ESSENCES (EXCLUDING CIGARS, INCL. CHEROOTS, CIGARILLOS AND CIGARETTES); HS CODE - 2403 (USD THOUSAND)
TABLE 3 USERS OF E-CIGARETTES, U.K., 2014-2019 (%)
TABLE 4 RISK REDUCTION ON SMOKING CESSATION
TABLE 5 RISK REDUCTION ON SMOKING CESSATION
TABLE 6 REGULATIONS OF DIFFERENT COUNTRIES
TABLE 7 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (MILLION UNITS)
TABLE 8 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 9 NORTH AMERICA WITH NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (MILLION UNITS)
TABLE 10 NORTH AMERICA WITH NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 11 NORTH AMERICA WITH NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 12 NORTH AMERICA NICOTINE LOZENGES IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY NICOTINE LOZENGES WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 13 NORTH AMERICA WITHOUT NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (MILLION UNITS)
TABLE 14 NORTH AMERICA WITHOUT NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 15 NORTH AMERICA WITHOUT NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITHOUT NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 16 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 17 NORTH AMERICA PHARMACOLOGICAL IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 18 NORTH AMERICA THERAPIES IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 19 NORTH AMERICA OTHERS IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 20 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 21 NORTH AMERICA OFFLINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 22 NORTH AMERICA OFFLINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 23 NORTH AMERICA ONLINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 24 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY END-USER, 2018-2027 (USD MILLION)
TABLE 25 NORTH AMERICA MILLENNIALS END-USER IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 26 NORTH AMERICA MILLENNIALS END-USER IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 27 NORTH AMERICA GENERATION Z END-USER IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 28 NORTH AMERICA GENERATION Z END-USER IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 29 NORTH AMERICA GENERATION X END-USER IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 30 NORTH AMERICA GENERATION X END-USER IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 31 NORTH AMERICA SILENT GENERATION END-USER IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 32 NORTH AMERICA SILENT GENERATION END-USER IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 33 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY COUNTRY, 2018-2027 (MILLION UNITS)
TABLE 34 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 35 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (MILLION UNITS)
TABLE 36 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 37 NORTH AMERICA WITH NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 38 NORTH AMERICA NICOTINE LOZENGES IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY NICOTINE LOZENGES WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 39 NORTH AMERICA WITHOUT NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITHOUT NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 40 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 41 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 42 NORTH AMERICA OFFLINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 43 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY END-USER, 2018-2027 (USD MILLION)
TABLE 44 NORTH AMERICA MILLENNIALS IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 45 NORTH AMERICA GENERATION Z IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 46 NORTH AMERICA GENERATION X IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 47 NORTH AMERICA SILENT GENERATION IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 48 U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (MILLION UNITS)
TABLE 49 U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 50 U.S. WITH NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 51 U.S. NICOTINE LOZENGES IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY NICOTINE LOZENGES WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 52 U.S. WITHOUT NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITHOUT NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 53 U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 54 U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 55 U.S. OFFLINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 56 U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY END-USER, 2018-2027 (USD MILLION)
TABLE 57 U.S. IN MILLENNIALS SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 58 U.S. GENERATION Z IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 59 U.S. GENERATION X IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 60 U.S. SILENT GENERATION IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 61 CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (MILLION UNITS)
TABLE 62 CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 63 CANADA WITH NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 64 CANADA NICOTINE LOZENGES IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY NICOTINE LOZENGES WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 65 CANADA WITHOUT NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITHOUT NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 66 CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 67 CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 68 CANADA OFFLINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 69 CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY END-USER, 2018-2027 (USD MILLION)
TABLE 70 CANADA MILLENNIALS IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 71 CANADA GENERATION Z IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 72 CANADA GENERATION X IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 73 CANADA SILENT GENERATION IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 74 MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (MILLION UNITS)
TABLE 75 MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 76 MEXICO WITH NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 77 MEXICO NICOTINE LOZENGES IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY NICOTINE LOZENGES WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 78 MEXICO WITHOUT NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITHOUT NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 79 MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 80 MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 81 MEXICO OFFLINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 82 MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY END-USER, 2018-2027 (USD MILLION)
TABLE 83 MEXICO MILLENNIALS IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 84 MEXICO GENERATION Z IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 85 MEXICO GENERATION X IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 86 MEXICO SILENT GENERATION IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
图片列表
LIST OF FIGURES
FIGURE 1 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: RESEARCH SNAPSHOT
FIGURE 4 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: THE PRODUCT TYPE LIFE LINE CURVE
FIGURE 7 MULTIVARIATE MODELLING FOR NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET
FIGURE 8 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: DBMR MARKET POSITION GRID
FIGURE 10 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: MARKET END-USER COVERAGE GRID
FIGURE 11 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 12 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: SEGMENTATION
FIGURE 13 GROWING AWARENESS AMONG POPULATION OWING TO INCREASING DISEASES FROM SMOKING IS A DRIVER OF SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
FIGURE 14 WITH NICOTINE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET IN 2020 TO 2027
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES & CHALLENGES IN NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET
FIGURE 16 POPULATION OF ADULT E-CIGARETTES USERS, U.K.,2014-2019 (PERCENTAGE)
FIGURE 17 CHINA PREVELANCE RATE OF SMOKING, MALE VS FEMALE, 2015 (IN PERCENTAGE)
FIGURE 18 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY PRODUCT TYPE, 2019
FIGURE 19 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY TREATMENT TYPE, 2019
FIGURE 20 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY DISTRIBUTION CHANNEL, 2019
FIGURE 21 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY END-USER, 2019
FIGURE 22 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: SNAPSHOT (2019)
FIGURE 23 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY COUNTRY (2019)
FIGURE 24 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY COUNTRY (2020 & 2027)
FIGURE 25 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY COUNTRY (2019 & 2027)
FIGURE 26 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY PRODUCT TYPE (2020-2027)
FIGURE 27 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: COMPANY SHARE 2019 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
